This article is from the source 'bbc' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at http://www.bbc.co.uk/news/business-27464667

The article has changed 6 times. There is an RSS feed of changes available.

Version 0 Version 1
Pfizer makes new £55 per share offer for AstraZeneca Pfizer makes new £55 per share offer for AstraZeneca
(35 minutes later)
Drugs giant Pfizer has made an improved offer of £55 per share for AstraZeneca.Drugs giant Pfizer has made an improved offer of £55 per share for AstraZeneca.
If the offer is accepted by AstraZeneca's board, it will be the largest takeover of a firm in British corporate history. If the offer - a mixture of shares and cash which values AstraZeneca at about £69bn - is accepted by its board, it will be the largest takeover of a firm in British corporate history.
The offer constitutes a 15% increase from Pfizer's proposal on 2 May.The offer constitutes a 15% increase from Pfizer's proposal on 2 May.
AstraZeneca shareholders are being offered a mixture of shares and cash, according to a statement from Pfizer. Pfizer plans to create the world's largest drug company, with its headquarters in New York, but based in the UK for tax purposes.
The new offer is final and cannot be increased, it said.
Not hostile
The US company increased the cash element of its bid and also promised not to mount a hostile takeover - that is, a direct approach to shareholders of AstraZeneca without the involvement of its board.
Shareholders are being offered £24.76 in cash and 1.747 shares in the new firm, worth a combined £55, per share they hold.
Both unions and politicians had voiced their concerns the company could cut UK jobs to save money.
But Pfizer chief executive Ian Read said in the statement: "We stand by our unprecedented commitments to the UK government."